MA34196B1 - IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS - Google Patents

IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS

Info

Publication number
MA34196B1
MA34196B1 MA34290A MA34290A MA34196B1 MA 34196 B1 MA34196 B1 MA 34196B1 MA 34290 A MA34290 A MA 34290A MA 34290 A MA34290 A MA 34290A MA 34196 B1 MA34196 B1 MA 34196B1
Authority
MA
Morocco
Prior art keywords
conditions
trpv3
imidazole derivatives
trpv3 antagonists
derivatives condensed
Prior art date
Application number
MA34290A
Other languages
French (fr)
Inventor
V S Prasadarao Lingam
Abraham Thomas
Shantaram Kashinath Phatangare
Ajit Shankar Mindhe
Javed Yusuf Khatik
Neelima Khairatkar-Joshi
Vidya Ganapati Kattige
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Priority to MA34290A priority Critical patent/MA34196B1/en
Publication of MA34196B1 publication Critical patent/MA34196B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des modulateurs de récepteur vanilloïde à potentiel de récepteur transitoire (TRVP) de formule (I). En particulier, les composés décrits dans l'invention sont utiles pour traiter ou prévenir des maladies, des états et/ou des affections modulés par TRPV3. L'invention concerne également des procédés de préparation des composés décrits ici, des intermédiaires utilisés dans leur synthèse, des compositions pharmaceutiques les contenant et des procédés de traitement ou de prévention de maladies, d'états et/ou d'affections modulés par TRPV3. (Formule I) (I)The present invention relates to vanilloid receptor modulators with transient receptor potential (TRVP) of formula (I). In particular, the compounds described in the invention are useful for treating or preventing TRPV3 modulated diseases, conditions and / or conditions. The invention also relates to methods for preparing the compounds described herein, intermediates used in their synthesis, pharmaceutical compositions containing them, and methods of treating or preventing TRPV3 modulated diseases, conditions, and / or conditions. (Formula I) (I)

MA34290A 2011-10-24 2011-10-24 IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS MA34196B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA34290A MA34196B1 (en) 2011-10-24 2011-10-24 IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA34290A MA34196B1 (en) 2011-10-24 2011-10-24 IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS

Publications (1)

Publication Number Publication Date
MA34196B1 true MA34196B1 (en) 2013-05-02

Family

ID=48901569

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34290A MA34196B1 (en) 2011-10-24 2011-10-24 IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS

Country Status (1)

Country Link
MA (1) MA34196B1 (en)

Similar Documents

Publication Publication Date Title
MA45223A (en) NEW PIPERIDINYL DERIVATIVES SUBSITATED BY (HETERO) ARYL, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TN2014000147A1 (en) (4-PHENYLIMIDAZOL-2-YL) ETHYLAMINE DERIVATIVES USEFUL AS SODIUM CHANNEL MODULATORS
MA30778B1 (en) SULFONAMIDE DERIVATIVES AS ADRENERGIC AGONISTS AND MUSCARINIC ANTAGONISTS
MA31447B1 (en) NOVEL DICARBOXYLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS
MA45222A (en) NEW PIPERIDINYL DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201001371A1 (en) Condensed pyrimidine compounds as modulators of TRPV3
MA30696B1 (en) (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL) -ACETIC DERIVATIVES
MA42239B1 (en) New hydroxyester derivatives, their preparation process and pharmaceutical compositions containing them
MA32035B1 (en) Tricyclic compounds act as modulators for tnf-alpha and as inhibitors for pde4
MA29839B1 (en) CARBOXAMIDE DERIVATIVES AS ANTAGONISTS OF MUSCARINIC RECEPTORS
MA31158B1 (en) Tricyclic compounds and their use as modifiers for glucocorticoid receptors.
MA32466B1 (en) TRIAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES
MA30289B1 (en) Derivatives of amines
MA29140B1 (en) Heteroaromatic quinoline derivatives and their use as PDE10 inhibitors
MA34174B1 (en) HETERARYL-CYCLOHEXYL-TETRAAZABENZO [E) AZULENES AS ANTAGONISTS OF VASOPRESSIN V1A RECEPTORS
EA201190004A1 (en) CONDENSED IMIDAZOLE CARBOXAMIDE AS TRPV3 MODULATORS
MA49127B1 (en) N-substituted indole derivatives
MA46342A (en) CHROMANE, ISOCHROMAN AND DIHYDROISOBENZOFURAN DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2, COMPOSITIONS AND THEIR USE
EA201000675A1 (en) CHROMAN DERIVATIVES AS TRPV3 MODULATORS
MX2011006821A (en) Fused imidazole derivatives as trpv3 antagonist.
MA31863B1 (en) PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS
MA39750B1 (en) Derivatives of aza-indol-acetic acid and their use as modulators of prostaglandin receptors d2
MA35102B1 (en) 7- (heteroaryl-amino) -6,7,8,9-tetrahydropyrido [1,2-a] indolacetic acid derivatives and their use as modulators of the prostaglandin d2 receptor
MA34196B1 (en) IMIDAZOLE DERIVATIVES CONDENSED AS TRPV3 ANTAGONISTS
EA201190003A1 (en) CHROMENON DERIVATIVES AS TRPV3 ANTAGONISTS